Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Gestational age 28-32 completed weeks, inclusive~* Placement of arterial line~* Successful initiation of nCPAP~* Informed Consent~Exclusion Criteria:~* Heart rate that cannot be stabilized \>100 bpm within 5 minutes of birth~* Five (5) minute Apgar score ≤ 3~* Major congenital malformation(s) diagnosed antenatally or noted immediately after birth~* Other disease(s) or conditions potentially interfering with cardiopulmonary function~* Mother with prolonged rupture of membranes \> 2 weeks~* Known or suspected chromosomal abnormality~* Need for chest compressions or administration of epinephrine, bicarbonate, or fluid boluses in the delivery room~* Need for mechanical ventilation within 30 minutes of birth

- Gender: ALL
- Minimum Age: 15 Minutes
- Maximum Age: 30 Minutes
- Healthy Volunteers: f

Study Arms:
- Regimen 1 (Type: EXPERIMENTAL): None
- Regimen 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).